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doi:10.1016/j.ejvs.2009.12.015Abstract We report our experience treating four patients with acutely bleeding angiomyoli-
poma (AML) of sizes between 4 and 12 cm who were managed with endovascular embolisation
with a mean follow-up of 10 months. In our case series, we demonstrate that endovascular
embolisation in the acute setting for bleeding AMLs is a viable treatment option. AML should
be in the differential diagnosis of acutely bleeding renal masses, even when there is no fat
assessed by computed tomography (CT) imaging in the renal mass.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Angiomyolipoma (AML) can be treated with conservative
management, catheter-directed embolisation of the
feeding renal artery or surgery.1e4 Currently, prophylactic
endovascular treatment of AML is widely accepted because
of the risk of AML bleeding.4e6 However, there are different
methods of treatment and few reports regarding the
management of patients presenting with acutely bleeding
renal AML.1,3,7,8 Our purpose is to review literature and
report our experience with four cases of acute renal AML
haemorrhage treated with catheter-directed embolisation.4 924 5775; fax: þ1 434 924
(U.C. Turba).
ty for Vascular Surgery. PublisheMaterials and Methods
After institutional review board approval was received,
a retrospective review of our Hi-IQ database (Conexs,
Providence, RI, USA) was undertaken between 1998 and
2008. We identified four patients with angiomyolipoma
who presented with retroperitoneal haemorrhage. Three
patients were treated with an ethanol:ethiodol (American
Recent, Shirley, NY, USA; Savage Laboratories, Melville,
NY, USA) mixture and one patient was treated with
polyvinyl alcohol (PVA) particles and coils (Cook, Bloo-
mington, IN, USA) because at presentation, the mass was
indeterminate which was subsequently identified as an
AML.d by Elsevier Ltd. All rights reserved.
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740 M. Incedayi et al.Results
Four patients (two men and two women) were identified
with a mean age of 38 years (range, 26e51 years). All had
acute haemorrhage identified on computed tomography
(CT). Three patients were embolised emergently, and one
pregnant patient was embolised electively post-partum
(Table 1). The treated tumours were all 4 cm in diameter or
larger. Two patients had elective additional AML emboli-
sations 3 and 5 months after primary procedure. In three
cases, an ethanol and ethiodol mixture was used, followed
by PVA and/or embospheres in the setting of acute
haemorrhage.
In case 1, renal angiogram demonstrated 11 cm angio-
myolipoma with active haemorrhage. An intervention was
performed with a renegade Hi-Flo microcatheter (Boston
Scientific, Natick, MA, USA). Approximately none 18 ml of
3:2 ethanol:ethiodol mixture was slowly injected, then
approximately 1.25 vials of PVA particles (250e355 mm)
were used to embolize the larger AML. In addition, there
was a capsular arterial branch feeding the tumour, which
required 2 ml of additional mixture of 3:2 ethanol:ethiodol
and PVA particles. The smaller AML (4 cm) was also treated
using approximately 13 ml of 3:2 ethanol:ethidol mixture
and 2 ml of PVA particles. Follow-up angiogram demon-
strated no arterial flow to either of the AMLs. Similar
approaches were used in cases 2 (Figs. 1e6) and 3.
Case 4 was unique, in that the presenting CT demon-
strated a large (12 cm) renal bleeding mass, but the CT
findings were not typical findings of AML (fat was not well
distinguished from blood products). Emergent left renal
angiogram was performed using a 5 French C2 Cobra cath-
eter (Cook, Bloomington, IN, USA) and selective renal
arteriogram demonstrated active extravasation of contrast
within two separate areas consistent with ongoing hae-
morrhage. Embolisation was performed with 500e700Figure 1 The left kidney demonstrates 6 cm fat containing
mass with surrounding hematoma. Blood layers in the left
pararenal space and anterior pararenal space.
Figure 2 There is a large vascular mass in the inferior pole of
the left kidney with extensive neovascularity and puddling of
contrast consistent with renal angiomyolipoma.
Figure 4 Post arteriogram demonstrates complete oblitera-
tion of the AML and stasis of flow to the inferior pole.
Successful alcohol and PVA particle embolization of the left
inferior pole of renal angiomyolipoma was achieved.
Renal Angiomyolipoma Presenting with Retroperitoneal Haemorrhage 741micron embospheres (Biosphere Medical, Rockland, IN,
USA). Post-embolisation angiograms confirmed successful
occlusion of the feeding artery of the bleeding mass. Then,
tornado coils (Cook Inc., Bloomington, IN, USA) were
deployed at the origin of the main feeding vessel to
completely seal the origin of the feeding artery. In the
emergent setting, the operators chose to use embospheres
and coils to stabilise the active haemorrhage. At that time,
AML diagnosis could not be established, which prompted
further evaluation with open exploration by a urologyFigure 3 An occlusion balloon catheter was positioned
within the feeding lower pole of renal artery and 4 ml of
dehydrated alcohol mixed with Lipiodol was infused (3:2
dilution).team to evaluate the nature of the mass lesion and for
possible partial nephrectomy. However, open biopsy later
confirmed AML.
Discussion
Radiological diagnosis of AML is confirmed by demonstration
of fatty tissue within the renal mass on CT or magnetic
resonance imaging (MRI). However, in 5e15% of cases the
fat component may not be visible.1,3 In case 4, fatty
component of the renal mass was masked by haemorrhage,
which was later diagnosed by open biopsy.Figure 5 Follow-up CT demonstrates decreased in size of the
left lower pole angiomyolipoma (19 months post embolization)
and resolution of the hematoma.
Figure 6 A) A sketch of renal angiomyolipoma showing a single vessel feeder of the mass. B) A sketch of an occlusion balloon that
was placed at the origin of the single feeder artery and embolization was performed through the same occlusion balloon. C) Post-
embolization sketch showing absence of tumor vascularity.
742 M. Incedayi et al.Possibly fatal haemorrhage is a well-described compli-
cation of AML. During the past two decades, superselective
renal artery embolotheraphy, sparing the normal renal
parenchyma, has become increasingly widespread in the
management of renal AMLs using alcohol:ethidol liquid
embolisation, particles or coils.2,3,6,9 In 1998, Lee et al.4
reported 87% success using iodised oil and absolute ethanol
mixture to prevent haemorrhagic complications. Although
many authors accepted this approach, Rimon et al.7
increased his clinical success (94%) by adding PVA at
completion (Table 2).
The natural history of AML is not well recognised.
However, it has been reported that AMLs increase in size
with time, but growth speed is not predictable.1 The major
risk of tumour progression is haemorrhage, which can be
life threatening. The haemorrhagic risk depends on not onlyits size, but also presence of multiple foci and intralesional
aneurysms.1,5 The incidence of haemorrhage remains
unknown. Most series demonstrate that patients presenting
with haemorrhage bleed from AMLs at least 4 cm in diam-
eter.1e3,7 Although there are very limited evidence-based
size criteria for prophylactic therapeutic management of
AMLs, empirically 4 cm is a widely accepted treatment
criteria.1,2,6,10
The appropriateness of embolisation during pregnancy
also remains uncertain. Dabbeche et al.1 reported two
cases of endovascular intervention during pregnancy, using
proper radiation protection measures. Morales et al.11
reported one case during 10 weeks of pregnancy with
normal delivery of infant 28 weeks later. Evidence-based
reports are very limited with pregnancy and AML haemor-
rhage, but, intuitively, haemorrhagic risk increases with
Table 2 Literature review.
Study
year
Number of
patients/
Number of
AMLs
embolized
Embolization
technique
Lesion
size
(cm)
Embolization
Emergent/
Prophylactic-
elective
Embolization
Technique
success
Clinical
success
Mean
follow-up
(months)
Earthman et al.9 1986 2/3 Absolute alcohol 4 < 2/0 100% 100% 24
Soulen et al.10 1994 5/5 Absolute alcohol
Absolute alcohol/
Ethiodol
4 < 0/5 100% 90% 21
Mourikis et al.3 1999 5/8 Polyvinyl alcohol,
Coils
5e12 5/0 100% 80% 5
Chiarugi et al.8 2000 1/Numerous Coils  4 1/0 100% Unknown/
mild renal
insufficiency
36
Kothary et al.6 2005 19/30 Ethanol/Ethiodol
Coils þ Ethanol/
Ethiodol
4 < 7/12 100% 70% 51
Rimon et al.7 2005 17/18 Ethanol and
Polyvinyl alcohol
particles
5.5e20 3/14 94% 94% 14
Dabbech et al.1 2006 34/35 Ethanol, Particles
Coils
4e11 16/19 80% 50% 18
Seyam et al.2 2008 29/6
(additionally
12 nephrectomy
11 partial
nephrectomy)
Ethanol 2e21 0/6 100% 83.3% 39
Current study 2009 4/6 Ethanol/Ethiodol
mixture Embospheres,
Polyvinyl alcohol
particles and Coils
4e12 3/3 100% 100% 10
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744 M. Incedayi et al.altered haemodymamics and external pressure similarly in
our case 3. In this case series, the clinical decision to defer
treatment until after deliver was made, but further
evidence is needed to dictate if this is safe practice.
In conclusion, embolisation in the acute setting for
bleeding AMLs appears effective and safe. The role of
emergent embolisation in pregnant patients with contained
acute haemorrhage AML remains unclear. The previously
reported ethiodol and alcohol mixture is well tolerated by
patients in combination with particle embolisation. Lastly,
AML should be in the differential diagnosis of acutely
bleeding renal masses, even when there is no fat in the
renal mass.
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